Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Cash Flows (Unaudited)

v3.19.1
Condensed Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended 18 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Mar. 31, 2019
Mar. 31, 2018
Sep. 30, 2018
Mar. 31, 2019
Operating Activities            
Net loss $ (247,272) $ 21,980 $ (411,375) $ (123,948)    
Adjustments to reconcile net loss to net cash used in operating activities:            
Interest earned on cash and marketable securities held in Trust Account     (1,492,607) (554,326)    
Interest receivable on cash and marketable securities held in Trust Account     (59,471)      
Change in operating assets and liabilities:            
Receivable from related party     6,229 (93,098)    
Prepaid expenses     64,603 (144,789)    
Accounts payable     1,155,957 54,474    
Payable to related party     19,922      
Accrued liabilities     (390,776)      
Other current liabilities     9,893 171,827    
Net cash used in operating activities     (1,097,625) (689,860)    
Investing Activities            
Investment of cash in Trust Account, net     (1,437,500) (143,750,000)    
Cash withdrawn from Trust Account     637,704   $ 379,123 $ 1,016,827
Net cash used in investing activities     (799,796) (143,750,000)    
Financing Activities            
Proceeds from sale of Units, net of underwriting discounts paid       141,162,440    
Proceeds from sale of Private Placement Units       4,982,560    
Proceeds from the sale of Founder Shares       25,000    
Promissory notes from related parties       50,536    
Repayment of promissory notes from related parties       (50,536)    
Payment of deferred offering costs       (579,498)    
Promissory notes for extension     1,437,500      
Net cash provided by financing activities     1,437,500 145,590,502    
Net change in cash and cash equivalents     (459,921) 1,150,642    
Cash and cash equivalents, beginning of period     597,268      
Cash and cash equivalents, end of period $ 137,347 $ 1,150,642 137,347 1,150,642 $ 597,268 $ 137,347
Supplemental disclosure of noncash investing activities            
Change in value of common stock subject to possible redemption     $ (411,375) $ (116,389)